| Michele K Nelsen, MD | |
|
14410 Se Petrovitsky Rd Ste 104, Renton, WA 98058-8900 | |
| (256) 903-4054 | |
| (425) 690-9405 |
| Full Name | Michele K Nelsen |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 29 Years |
| Location | 14410 Se Petrovitsky Rd Ste 104, Renton, Washington |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093729873 | NPI | - | NPPES |
| 1042822 | Medicaid | WA | |
| G8891361 | Other | WA | MEDICARE W VALLEY MEDICAL GROUP - RENTON |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207VX0000X | Obstetrics & Gynecology - Obstetrics | MD00035357 (Washington) | Secondary |
| 207Q00000X | Family Medicine | MD00035357 (Washington) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Valley Medical Center | Renton, WA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Valley Medical Group-renton | 4183753965 | 408 |
News Archive
A new kind of antibody targets a feature shared by proteins thought to cause the most damage in Alzheimer's disease, Parkinson's disease, and related conditions, creating potential for a unified treatment approach.
Celgene Corporation today announced that the U.S. Food and Drug Administration (FDA) has granted Priority Review classification to its Supplemental New Drug Application (sNDA) regarding ISTODAX (romidepsin) for injection for the treatment of peripheral T-cell lymphoma (PTCL) in patients who have received at least one prior therapy.
Whether or not cognitive behavior therapy (CBT) will help a person recover from depression can be predicted through brain imaging, according to research results published by the University of Pittsburgh School of Medicine in the April issue of the American Journal of Psychiatry.
ProPublica, Reuters and The Huffington Post won gold, silver and bronze awards, respectively, in the eighth annual Barlett & Steele Awards for Investigative Business Journalism, the Donald W. Reynolds National Center for Business Journalism announced today.
› Verified 8 days ago
| Entity Name | Valley Medical Group-renton |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1619209574 PECOS PAC ID: 4183753965 Enrollment ID: O20100604000113 |
News Archive
A new kind of antibody targets a feature shared by proteins thought to cause the most damage in Alzheimer's disease, Parkinson's disease, and related conditions, creating potential for a unified treatment approach.
Celgene Corporation today announced that the U.S. Food and Drug Administration (FDA) has granted Priority Review classification to its Supplemental New Drug Application (sNDA) regarding ISTODAX (romidepsin) for injection for the treatment of peripheral T-cell lymphoma (PTCL) in patients who have received at least one prior therapy.
Whether or not cognitive behavior therapy (CBT) will help a person recover from depression can be predicted through brain imaging, according to research results published by the University of Pittsburgh School of Medicine in the April issue of the American Journal of Psychiatry.
ProPublica, Reuters and The Huffington Post won gold, silver and bronze awards, respectively, in the eighth annual Barlett & Steele Awards for Investigative Business Journalism, the Donald W. Reynolds National Center for Business Journalism announced today.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Michele K Nelsen, MD 3600 Lind Ave Sw, Ste 100 Attn Credentialing, Renton, WA 98057-4970 Ph: (425) 690-2715 | Michele K Nelsen, MD 14410 Se Petrovitsky Rd Ste 104, Renton, WA 98058-8900 Ph: (256) 903-4054 |
News Archive
A new kind of antibody targets a feature shared by proteins thought to cause the most damage in Alzheimer's disease, Parkinson's disease, and related conditions, creating potential for a unified treatment approach.
Celgene Corporation today announced that the U.S. Food and Drug Administration (FDA) has granted Priority Review classification to its Supplemental New Drug Application (sNDA) regarding ISTODAX (romidepsin) for injection for the treatment of peripheral T-cell lymphoma (PTCL) in patients who have received at least one prior therapy.
Whether or not cognitive behavior therapy (CBT) will help a person recover from depression can be predicted through brain imaging, according to research results published by the University of Pittsburgh School of Medicine in the April issue of the American Journal of Psychiatry.
ProPublica, Reuters and The Huffington Post won gold, silver and bronze awards, respectively, in the eighth annual Barlett & Steele Awards for Investigative Business Journalism, the Donald W. Reynolds National Center for Business Journalism announced today.
› Verified 8 days ago
Dominique James Nguyen, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3915 Talbot Rd S Ste 200, Renton, WA 98055 Phone: 425-690-3400 Fax: 425-690-0600 | |
Dr. Tory John Olsen, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 400 S 43rd St, Renton, WA 98055 Phone: 425-656-4224 | |
Anna Eleanor Goebel, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3901 Ne 4th St Ste 105, Renton, WA 98056 Phone: 425-690-3410 Fax: 425-690-9410 | |
Sumam Marion Abraham, Family Medicine Medicare: Medicare Enrolled Practice Location: 275 Bronson Way Ne, Renton, WA 98056 Phone: 425-235-2800 | |
John L. Bondi, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 3915 Talbot Rd S, Ste 401, Renton, WA 98055 Phone: 425-656-4224 | |
Arkadiy B. Tkachev, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 601 S Carr Rd, Suite 100, Renton, WA 98055 Phone: 415-227-3700 | |
Daniel L Brelsford, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3901 Ne 4th St, Ste 105, Renton, WA 98056 Phone: 425-690-3410 Fax: 425-690-9410 |